Daridorexant 50 mg trials for Alzheimer's disease

All Daridorexant 50 mg trials · All Alzheimer's disease trials

Phase breakdown

Recruiting trials studying Daridorexant 50 mg for Alzheimer's disease

• Daridorexant for Alzheimer Disease Prevention
  NCT07213349 · Phase: Phase 2 · Ages: 50 Years to 90 Years · Sex: All (male and female) · 1 location
• Daridorexant to Prevent Post-cardiotomy Delirium
  NCT07217912 · Phase: Phase 2 · Ages: 60 Years and older · Sex: All (male and female) · 1 location
• Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease
  NCT05924425 · Phase: Phase 4 · Ages: 60 Years to 85 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Daridorexant 50 mg for Alzheimer's disease?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.